Marksans Pharma Assigned ESG Score 56 by Crisil

Key Quantitative Figures

Crisil ESG Ratings & Analytics Ltd assigned an ESG Score of "56" to Marksans Pharma Limited.

Basis of Assessment

The ESG rating was voluntarily reviewed by Crisil ESG Ratings & Analytics Ltd, which is a SEBI Licensed ESG Rating Provider (ERP). The assessment was based on data available in the public domain for Fiscal 2026.

Accessibility

The assigned ESG score can be accessed on the BSE website at the provided URL: https://www.bseindia.com/stock-share-price/marksans-pharma-ltd/marksans/524404/intermediaries-ERP/

Financial Impact

Financial impact not quantified in the disclosure. The filing is explicitly stated to be for information and record purposes only.